Trevi Therapeutics, Inc. TRVI Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $35.61M+6.4% | $33.48M-8.6% | $36.61M-3.0% | $37.75M-1.6% | $38.38M-2.5% | ||
| $17.16M+8.3% | $15.85M+7.5% | $14.74M+7.0% | $13.77M+8.4% | $12.71M+4.6% | ||
| $52.77M+7.0% | $49.33M-3.9% | $51.35M-0.3% | $51.52M+0.8% | $51.09M-0.8% | ||
| -$52.77M-7.0% | -$49.33M+3.9% | -$51.35M+0.3% | -$51.52M-0.8% | -$51.09M+0.8% | ||
| $7.09M+8.9% | $6.51M+19.1% | $5.46M+30.8% | $4.18M+12.7% | $3.71M+3.4% | ||
| -$45.68M-6.7% | -$42.82M+6.7% | -$45.89M+3.1% | -$47.35M+0.1% | -$47.38M+1.2% | ||
| -$72K-14.3% | -$63K— | —— | —— | —— | ||
| -$45.61M-6.7% | -$42.76M+6.8% | -$45.86M+3.0% | -$47.3M+0.1% | -$47.35M+1.2% | ||
| -$0.320.0% | -$0.32+13.5% | -$0.37+11.9% | -$0.42+6.7% | -$0.45+4.3% | ||
| -$52.63M-7.0% | -$49.18M+3.9% | -$51.2M+0.3% | -$51.37M-0.9% | -$50.94M+0.9% | ||
| -$52.77M-7.0% | -$49.33M+3.9% | -$51.35M+0.3% | -$51.52M-0.8% | -$51.09M+0.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Trevi Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Trevi Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.